These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13903975)

  • 41. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M; Berger R; Just V
    Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques.
    Pasetti MF; Resendiz-Albor A; Ramirez K; Stout R; Papania M; Adams RJ; Polack FP; Ward BJ; Burt D; Chabot S; Ulmer J; Barry EM; Levine MM
    Clin Pharmacol Ther; 2007 Dec; 82(6):672-85. PubMed ID: 17971812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trial of a reduced dose of measles vaccine in Nigerian children.
    Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
    Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Experience in vaccinatkon with attenuated measles vaccine. I. Preliminary report on clinical aspects].
    MENEGHELLO J; UNDURRAGA O; ROSSELOT V; HEVIA P
    Pediatria (Santiago); 1962; 5():223-32. PubMed ID: 14472599
    [No Abstract]   [Full Text] [Related]  

  • 45. The development and evaluation of an attenuated measles virus vaccine.
    KATZ SL; ENDERS JF; HOLLOWAY A
    Am J Public Health Nations Health; 1962 Feb; 52(2)Suppl(Suppl 2):5-10. PubMed ID: 14454407
    [No Abstract]   [Full Text] [Related]  

  • 46. Preliminary tests of a highly attenuated measles vaccine.
    SCHWARZ AJ
    Am J Dis Child; 1962 Mar; 103():386-9. PubMed ID: 13909753
    [No Abstract]   [Full Text] [Related]  

  • 47. Combined live measles, mumps, rubella vaccine. Immunological response.
    Krugman S; Muriel G; Fontana VJ
    Am J Dis Child; 1971 May; 121(5):380-1. PubMed ID: 5091532
    [No Abstract]   [Full Text] [Related]  

  • 48. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. THE EFFECT OF MEASLES, GAMMA GLOBULIN MODIFIED MEASLES, AND ATTENUATED MEASLES VACCINE ON THE COURSE OF TREATED TUBERCULOSIS IN CHILDREN.
    STARR S; BERKOVICH S
    Pediatrics; 1965 Jan; 35():97-102. PubMed ID: 14223232
    [No Abstract]   [Full Text] [Related]  

  • 50. New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules.
    El Kasmi KC; Muller CP
    Vaccine; 2001 Mar; 19(17-19):2238-44. PubMed ID: 11257340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A systematic review of human-to-human transmission of measles vaccine virus.
    Greenwood KP; Hafiz R; Ware RS; Lambert SB
    Vaccine; 2016 May; 34(23):2531-6. PubMed ID: 27083423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Current problems in measles. II. Measles vaccines--recent progress].
    Ciufecu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(3):259-78. PubMed ID: 6438773
    [No Abstract]   [Full Text] [Related]  

  • 53. [On vaccination against measles with live and attenuated virus (Schwarz strain)].
    Monaci V; Imperato C; Battistini A; Nardi G; Grzincich GL; Bellelli E; Mazzeo G
    Ann Sclavo; 1973; 15(3):134-40. PubMed ID: 4776383
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
    Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
    Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
    [No Abstract]   [Full Text] [Related]  

  • 55. Response to live attenuated measles vaccine in children with severe kwashiorkor.
    Powell GM
    Ann Trop Paediatr; 1982 Sep; 2(3):143-5. PubMed ID: 6191631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exaggerated natural measles following attenuated virus immunization.
    St Geme JW; George BL; Bush BM
    Pediatrics; 1976 Jan; 57(1):148-9. PubMed ID: 1246490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental vaccines against measles in a world of changing epidemiology.
    Pütz MM; Bouche FB; de Swart RL; Muller CP
    Int J Parasitol; 2003 May; 33(5-6):525-45. PubMed ID: 12782053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination against acute respiratory virus infections and measles in man.
    Osterhaus AD; de Vries P
    Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on an attenuated measles-virus vaccine. III. Clinical and antigenic effects of vaccine in institutionalized children.
    KEMPE CH; OTT EW; ST VINCENT L; MAISEL JC
    N Engl J Med; 1960 Jul; 263():162-5. PubMed ID: 14408453
    [No Abstract]   [Full Text] [Related]  

  • 60. Studies on an attenuated measles-virus vaccine. VII. Clinical, antigenic and prophylactic effects of vaccine in home-dwelling children.
    HAGGERTY RJ; MEYER RJ; LENIHAN E; KATZ SL
    N Engl J Med; 1960 Jul; 263():178-80. PubMed ID: 13851871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.